The maker of the GLP-1 weight-loss drug Wegovy is promising “a lower, predictable monthly price” for patients who use a new subscription program for the medication. The savings add up to $600 a year ...

Over 40% of people taking Xenical achieved a 5% decrease in their starting body weight. Saxenda users achieved a 5% decrease in their body weight in more than 63% of cases. Eating a balanced diet and ...

The Food and Drug Administration on April 1 approved Eli Lilly's new weight-loss pill, giving consumers a second option in the growing non-injectable GLP-1 weight-loss drug market. Lilly said it will ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

Karol G posed topless for the latest issue of Playboy. She credited her friend Sofía Vergara for encouraging her to pose for the magazine, revealing that she's the "only person" that she asked before ...

Novo Nordisk A/S’s obesity drug Wegovy will be an option for about 1.2 million more patients in England’s National Health Service, after the drug price regulator recommended it to prevent heart ...

When it comes to using AI, it seems lawyers just can't help themselves. Last year saw a rapid increase in court sanctions against attorneys for filing briefs containing errors generated by artificial ...